Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/10
End: 05/20/24
Due: 05/20/25
Phase: N/A
Priority: Normal
Start: 07/11/24
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 03/31/29
Due: 03/31/30
Phase: N/A
Priority: Normal
Start: 01/29/25
End: 12/01/27
Due: 12/01/28
Phase: N/A
Priority: Normal
Start: 04/10/18
End: 06/30/31
Due: 06/30/32
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines | NCT06355219 | Ali Aminian | user2@example.com | None | 2010-01-01 | 2024-05-20 | 2025-05-20 | - | - | 2025-07-14 |
| Fibrosis Lessens After Metabolic Surgery | NCT06374875 | Ali Aminian | user2@example.com | None | 2024-07-11 | 2029-12-31 | 2030-12-31 | - | - | 2025-07-14 |
| Metabolic Surgery for Atrial Fibrillation Elimination | NCT07027969 | Ali Aminian | user2@example.com | None | 2025-08-01 | 2029-03-31 | 2030-03-31 | - | - | 2025-07-14 |
| Bariatric Surgery vs. Semaglutide vs. Tirzepatide | NCT06803888 | Ali Aminian | user2@example.com | None | 2025-01-29 | 2027-12-01 | 2028-12-01 | - | - | 2025-07-14 |
| Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes | NCT02328599 | Ali Aminian | user2@example.com | None | 2018-04-10 | 2031-06-30 | 2032-06-30 | - | - | 2025-07-14 |